Mind Medicine Inc (NASDAQ:MNMD) has a beta value of 2.39 and has seen 0.37 million shares traded in the recent trading session. The company, currently valued at $436.01M, closed the recent trade at $5.78 per share which meant it lost -$0.07 on the day or -1.11% during that session. The MNMD stock price is -111.42% off its 52-week high price of $12.22 and 12.98% above the 52-week low of $5.03. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.18 million shares traded. The 3-month trading volume is 2.00 million shares.
The consensus among analysts is that Mind Medicine Inc (MNMD) is Buy stock at the moment, with a recommendation rating of 1.36. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.37.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Sporting -1.11% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MNMD stock price touched $5.78 or saw a rise of 15.37%. Year-to-date, Mind Medicine Inc shares have moved -16.88%, while the 5-day performance has seen it change -14.68%. Over the past 30 days, the shares of Mind Medicine Inc (NASDAQ:MNMD) have changed -4.70%. Short interest in the company has seen 11.37 million shares shorted with days to cover at 4.92.
Wall Street analysts have a consensus price target for the stock at $16, which means that the shares’ value could jump 63.87% from the levels at last check today. The projected low price target is $16.0 while the price target rests at a high of $16.0. In that case, then, we find that the latest price level in today’s session is -176.82% off the targeted high while a plunge would see the stock gain -176.82% from the levels at last check today.
Mind Medicine Inc (MNMD) estimates and forecasts
The company’s shares have lost -1.11% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 10.40% over the past 5 years.
MNMD Dividends
Mind Medicine Inc is expected to release its next earnings report on 2025-Mar-05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Insiders own 1.49% of the company shares, while shares held by institutions stand at 55.75% with a share float percentage of 56.59%. Investors are also buoyed by the number of investors in a company, with Mind Medicine Inc having a total of 229.0 institutions that hold shares in the company. The top two institutional holders are COMMODORE CAPITAL LP with over 7.15 million shares worth more than $51.52 million. As of 2024-06-30, COMMODORE CAPITAL LP held 9.9369% of shares outstanding.
The other major institutional holder is DEEP TRACK CAPITAL, LP, with the holding of over 6.1 million shares as of 2024-06-30. The firm’s total holdings are worth over $44.01 million and represent 8.4879% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. As of Feb 28, 2025, the former fund manager holds about 2.77% shares in the company for having 2.09 shares of worth $12.02 million while later fund manager owns 988.95 shares of worth $5.7 million as of Dec 31, 2024, which makes it owner of about 1.31% of company’s outstanding stock.
